Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Neamin
2. Neomycin A
1. Neomycin A
2. 3947-65-7
3. Negamicin
4. Nebramycin X
5. Dekamycin V
6. Neamin
7. 4-o-(2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl)-2-deoxy-d-streptamine
8. 2-desoxy-4-o-(2,6-diamino-2,6-didesoxy-alpha-d-glucopyranosyl)-d-streptamin
9. Chebi:7489
10. (1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-d-glucopyranoside
11. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2h-pyran-3,4-diol
12. 5981u00ly0
13. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxyoxane-3,4-diol
14. (1r,3s,3s,5r,6r)-5-amino-2-aminomethyl-6-(4,6-diamino-2,3-dihydroxy-cyclohexyloxy)-tetrahydro-pyran-3,4-diol
15. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
16. (2r,3s,4r,5r,6r)-6-((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-5-amino-2-(aminomethyl)-tetrahydro-2h-pyran-3,4-diol
17. Xxx
18. Brn 0026714
19. Unii-5981u00ly0
20. Neamine [mi]
21. D-streptamine, 2-deoxy-4-o-(2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl)-
22. (+)-neamine
23. 4-18-00-07474 (beilstein Handbook Reference)
24. Schembl219578
25. Bdbm8580
26. Chembl427409
27. St 7
28. Dtxsid7023358
29. Hy-n7449
30. Zinc4095654
31. Mfcd00023857
32. Akos025311197
33. Db04808
34. D-streptamine, 2-deoxy-4-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl)-
35. Neomycin Sulfate Ep Impurity A (neamine)
36. Tobramycin Impurity C [ep Impurity]
37. Cs-0129171
38. C01441
39. 947n657
40. A824565
41. Neomycin Sulfate Impurity A [ep Impurity]
42. Q6984256
43. 2-deoxy-4-o-(2,6-diamine-2,6-dideoxy-.alpha.-d-glucopyranosyl)-d-streptamine
44. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-(((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl)oxy)tetrahydro-2h-pyran-3,4-diol Hydrochloride
45. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-tetrahydro-2h-pyran-3,4-diol
46. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-((1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyloxy)tetrahydro-2h-pyran-3,4-diol
47. (2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-{[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}oxane-3,4-diol
48. O-2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranosyl-(1->4)-1,3-diamino-1,2,3-trideoxy-d-myo-inositol
49. Wurcs=2.0/1,1,0/[a2122h-1a_1-5_1*oc^rc^rc^sc^rcc^s$3/8n/6n/5o/4o_2*n_6*n]/1/
| Molecular Weight | 322.36 g/mol |
|---|---|
| Molecular Formula | C12H26N4O6 |
| XLogP3 | -5.4 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 3 |
| Exact Mass | 322.18523456 g/mol |
| Monoisotopic Mass | 322.18523456 g/mol |
| Topological Polar Surface Area | 204 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 378 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Neamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neamine, including repackagers and relabelers. The FDA regulates Neamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Neamine supplier is an individual or a company that provides Neamine active pharmaceutical ingredient (API) or Neamine finished formulations upon request. The Neamine suppliers may include Neamine API manufacturers, exporters, distributors and traders.
Neamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Neamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Neamine GMP manufacturer or Neamine GMP API supplier for your needs.
A Neamine CoA (Certificate of Analysis) is a formal document that attests to Neamine's compliance with Neamine specifications and serves as a tool for batch-level quality control.
Neamine CoA mostly includes findings from lab analyses of a specific batch. For each Neamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Neamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Neamine EP), Neamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Neamine USP).
LOOKING FOR A SUPPLIER?
